ABBVIE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 166.6 USD | +0.14% |
|
+0.52% | +7.75% |
| 06-13 | AbbVie inks immune disorder drug licensing deal with China's FutureGen | RE |
| 06-13 | AbbVie, FutureGen in License Pact for Inflammatory Bowel Disease Drug | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 293B | ||||||
| 781B | ||||||
| 350B | - | - | - | - | ||
| 330B | ||||||
| 248B | ||||||
| 221B |
